Cardiologist-Investigator; Assistant Professor of Medicine
Massachusetts General Hospital
Harvard Medical School
Boston, Massachusetts, United States
Michael C. Honigberg, MD, MPP, FACC, FAHA is a cardiologist-investigator in the Cardiology Division at Massachusetts General Hospital (MGH), Director of Research for the MGH Women’s Heart Health Program, Assistant Professor of Medicine at Harvard Medical School, Associate Member of the MGH Center for Genomic Medicine, and Associate Member of the Broad Institute of MIT and Harvard. He received his MD from Harvard Medical School and MPP from the Harvard Kennedy School, completed internal medicine residency at Brigham and Women’s Hospital, and subsequently completed clinical and research fellowship training in cardiovascular medicine at MGH.
Dr. Honigberg’s research integrates epidemiology, human genetics, multi-omics, cardiovascular imaging, clinical trials, and implementation science to advance cardiovascular disease prevention. His program focuses on three interconnected areas: (1) understanding how pregnancy-related and reproductive risk factors influence cardiovascular disease in women; (2) defining the role of clonal hematopoiesis and genomic aging in cardiovascular disease and identifying therapeutic strategies to mitigate their effects; and (3) developing innovative approaches to improve the prevention and management of hypertension, dyslipidemia, and other cardiovascular risk factors. His work spans large population cohorts, deeply phenotyped clinical studies, mechanistic investigations, and randomized clinical trials.
Dr. Honigberg has led seminal studies defining the cardiovascular consequences of adverse pregnancy outcomes and reproductive aging, as well as the cardiovascular implications of clonal hematopoiesis. He led the largest genome-wide association study of preeclampsia and gestational hypertension to date, published in Nature Medicine, which identified novel genetic determinants of hypertensive disorders of pregnancy and their shared biology with cardiovascular disease. His research has also provided important insights into the role of clonal hematopoiesis in atherosclerotic cardiovascular disease, heart failure, arrhythmias, and valvular heart disease.
His research is supported by the National Heart, Lung, and Blood Institute, the American Heart Association, industry partnerships, and other sponsors. Dr. Honigberg serves as Associate Editor of the Journal of the American College of Cardiology (JACC) and Chair-Elect of the American College of Cardiology’s Cardiovascular Disease in Women Committee. He is the recipient of the 2023 Douglas P. Zipes Distinguished Young Scientist Award from the American College of Cardiology, and the 2024 Young Physician-Scientist Award from the American Society for Clinical Investigation.
Disclosure information not submitted.
Adverse Outcomes in Pregnancy: Future Cardiovascular Risks
Wednesday, October 14, 2026
2:20 PM - 2:40 PM EDT
Afternoon Panel Discussion and Q&A
Wednesday, October 14, 2026
4:20 PM - 5:00 PM EDT